# A Study to Compare the Pharmacokinetics Profile of DWCZP Tablet 100mg and Clozaril® Tablet 100mg

> **NCT01654601** · PHASE1 · COMPLETED · sponsor: **Dong Wha Pharmaceutical Co. Ltd.** · enrollment: 28 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** DWCZP
- **DRUG:** Clozaril

## Key facts

- **NCT ID:** NCT01654601
- **Lead sponsor:** Dong Wha Pharmaceutical Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2013-04
- **Final completion:** 2013-08
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2017-03-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01654601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01654601, "A Study to Compare the Pharmacokinetics Profile of DWCZP Tablet 100mg and Clozaril® Tablet 100mg". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01654601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*